Orthocell spikes on research result

Nerve technology developer Orthocell (ASX:OCC) has reported a study validating ‘high quality nerve repair’ from its CelGro treatment. The pre-clinical study indicated CelGro facilitated the regeneration of severed peripheral nerves, returning them to normal nerve structure. This reinforces earlier human trials that CelGro restored nerve sensation, reducing the need for sutures. Orthocell managing director, Paul…

Aristocrat and Ainsworth headed for court

Australia’s two leading manufacturers of gaming machines, Aristocrat Leisure (ASX: ALL) and Ainsworth Game Technology (ASX: AGI) are headed for a hard-fought patent battle in the federal court. Ainsworth announced it would be vigorously defending action by Aristocrat that alleges it infringed the comppany’s patent rights and Australian Consumer Law. Aristocrat maintains Ainsworth stole technology…